結果ページ2 セクター：医療 産業：製薬会社（一般） 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
全取引所
- {{item.name}}
- 全取引所
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (2)
- IOB (17)
- Istanbul (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (8)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (5)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (6)
- Shenzhen (6)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
製薬会社（一般） (265)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Johnson & Johnson JNJ.MX | $2,912.67 172.47 USD |
+1.06
|
$7.01T 414.96B USD | $18 1.07 USD | $2,912.67 172.47 USD | $2,912.67 172.47 USD | $7.01T 414.96B USD | 16.66 | $174.76 10.35 USD | |
| Johnson & Johnson JNJB34.SA | $55.89 11.33 USD |
+1.25
|
$2.02T 408.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.02T 408.84B USD | 16.68 | $3.35 0.68 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV.MX | $3,534 209.26 USD |
-0.37
|
$6.26T 370.7B USD | $9 0.53 USD | $3,534 209.26 USD | $3,534 209.26 USD | $6.26T 370.7B USD | 78.74 | $44.88 2.66 USD | |
| AbbVie Inc. ABBV34.SA | $64.32 13.04 USD |
-1.73
|
$1.82T 368.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.82T 368.45B USD | 81.41 | $0.79 0.16 USD | |
| Johnson & Johnson JNJ.VI | $131.1 143.31 USD |
+0.52
|
$317.38B 346.94B USD | $0 0 USD | $131.1 143.31 USD | $131.18 143.4 USD | $317.38B 346.94B USD | 16.78 | $7.81 8.54 USD | |
| Johnson & Johnson JNJ.F | $131.5 143.75 USD |
+0.41
|
$317.03B 346.56B USD | $8 8.75 USD | $131.5 143.75 USD | $131.5 143.75 USD | $317.03B 346.56B USD | 16.77 | $7.84 8.57 USD | |
| Novartis AG NVS.BA | $35,325 41.76 USD |
+1.29
|
$271.62T 321.06B USD | $170 0.2 USD | $35,250 41.67 USD | $35,425 41.87 USD | $271.62T 321.06B USD | 2.34 | $15.08K 17.83 USD | |
| AbbVie Inc. 4AB.F | $161.2 176.21 USD |
+1.77
|
$287.6B 314.38B USD | $97 106.03 USD | $159.6 174.46 USD | $161.2 176.21 USD | $287.6B 314.38B USD | 80.19 | $2.01 2.2 USD | |
| AbbVie Inc. 4AB.DE | $160.4 175.34 USD |
+1.01
|
$285.45B 312.03B USD | $2 2.19 USD | $159 173.81 USD | $159 173.81 USD | $285.45B 312.03B USD | 79.01 | $2.03 2.22 USD | |
| AbbVie Inc. ABBV.VI | $160.2 175.12 USD |
+0.88
|
$285.09B 311.64B USD | $0 0 USD | $160.2 175.12 USD | $160.4 175.34 USD | $285.09B 311.64B USD | 78.91 | $2.03 2.22 USD | |
| AstraZeneca PLC AZN.BA | $42,000 49.65 USD |
+0.3
|
$254.12T 300.37B USD | $121 0.14 USD | $41,825 49.44 USD | $42,125 49.79 USD | $254.12T 300.37B USD | 7.22 | $5.82K 6.88 USD | |
| Roche Holding AG ROGN.MX | $6,365.83 376.94 USD |
0
|
$4.94T 292.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.94T 292.46B USD | 26.24 | $242.54 14.36 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Merck & Co., Inc. MRK.BA | $19,100 22.58 USD |
+0.53
|
$236.26T 279.26B USD | $7.16K 8.47 USD | $18,800 22.22 USD | $19,325 22.84 USD | $236.26T 279.26B USD | 0.23 | $80.71K 95.41 USD | |
| Novartis AG NVSN.MX | $2,092.19 123.88 USD |
0
|
$4.43T 262.25B USD | $0 0 USD | $2,092.19 123.88 USD | $2,092.19 123.88 USD | $4.43T 262.25B USD | 17.03 | $122.81 7.27 USD | |
| Novartis AG N1VS34.SA | $64.93 13.16 USD |
+2.33
|
$1.28T 259.93B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.28T 259.93B USD | 18.03 | $3.6 0.73 USD | |
| Roche Holding AG RHHBF | $333.36 — |
0
|
$253.53B — | $61 — | $346.01 — | $346.01 — | $253.53B — | 26.43 | $12.61 — | |
| AstraZeneca PLC AZNN.MX | $1,332.55 78.9 USD |
-5.96
|
$4.14T 245.36B USD | $14 0.83 USD | $1,332.55 78.9 USD | $1,332.55 78.9 USD | $4.14T 245.36B USD | 29.67 | $44.91 2.66 USD | |
| AstraZeneca PLC A1ZN34.SA | $64.82 13.14 USD |
-0.11
|
$1.21T 244.4B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.21T 244.4B USD | 28.42 | $2.28 0.46 USD | |
| Roche Holding AG RHO6.F | $34.8 38.04 USD |
+0.06
|
$223.08B 243.86B USD | $230 251.42 USD | $34.8 38.04 USD | $34.8 38.04 USD | $223.08B 243.86B USD | 25.40 | $1.37 1.5 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Merck & Co., Inc. MRK.MX | $1,512 89.53 USD |
-1.18
|
$3.85T 228.11B USD | $29 1.72 USD | $1,512 89.53 USD | $1,512 89.53 USD | $3.85T 228.11B USD | 11.56 | $130.79 7.74 USD | |
| Merck & Co., Inc. MRCK34.SA | $55.33 11.21 USD |
-0.16
|
$1.11T 225.28B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.11T 225.28B USD | 11.67 | $4.74 0.96 USD | |
| AstraZeneca PLC AZNCF | $142.01 — |
0
|
$220.15B — | $331 — | $140.72 — | $140.72 — | $220.15B — | 28.57 | $4.97 — | |
| Novartis AG NOTA.F | $100 109.31 USD |
+0.4
|
$200.73B 219.43B USD | $1 1.09 USD | $100 109.31 USD | $100 109.31 USD | $200.73B 219.43B USD | 17.79 | $5.62 6.14 USD | |
| AstraZeneca PLC ZEGA.F | $62 67.77 USD |
0
|
$192.23B 210.13B USD | $200 218.63 USD | $60.5 66.13 USD | $62 67.77 USD | $192.23B 210.13B USD | 27.55 | $2.25 2.46 USD | |
| Amgen Inc. AMGN.BA | $11,000 13 USD |
+2.09
|
$174.78T 206.6B USD | $1.42K 1.67 USD | $10,700 12.65 USD | $11,100 13.12 USD | $174.78T 206.6B USD | 0.16 | $65.35K 77.24 USD | |
| AstraZeneca PLC ZEG.F | $121.25 132.54 USD |
-0.57
|
$187.96B 205.47B USD | $1.9K 2.08K USD | $121.25 132.54 USD | $121.25 132.54 USD | $187.96B 205.47B USD | 28.19 | $4.3 4.7 USD | |
| Merck & Co., Inc. MRK.SN | $79.09 — |
0
|
$201.69B — | $0 — | $0 — | $0 — | $201.69B — | 11.49 | $6.88 — | |
| Pfizer Inc. PFE.BA | $7,200 8.51 USD |
+1.12
|
$161.9T 191.37B USD | $11.72K 13.85 USD | $7,150 8.45 USD | $7,270 8.59 USD | $161.9T 191.37B USD | 2.21 | $3.26K 3.85 USD | |
| Merck & Co., Inc. 6MK.DE | $69.4 75.86 USD |
+0.29
|
$174.4B 190.65B USD | $111 121.34 USD | $69.3 75.75 USD | $69.3 75.75 USD | $174.4B 190.65B USD | 11.45 | $6.06 6.62 USD | |
| Merck & Co., Inc. MRK.VI | $69.3 75.75 USD |
+0.14
|
$174.15B 190.37B USD | $0 0 USD | $69.3 75.75 USD | $69.3 75.75 USD | $174.15B 190.37B USD | 11.49 | $6.03 6.59 USD | |
| Merck & Co., Inc. 6MK.F | $69.2 75.64 USD |
-0.29
|
$173.76B 189.95B USD | $42 45.91 USD | $69 75.43 USD | $69.2 75.64 USD | $173.76B 189.95B USD | 11.40 | $6.07 6.64 USD | |
| Gilead Sciences, Inc. GILD.BA | $31,850 37.65 USD |
+1.27
|
$156.21T 184.64B USD | $175 0.21 USD | $31,775 37.56 USD | $32,100 37.94 USD | $156.21T 184.64B USD | 5.66 | $5.62K 6.65 USD | |
| Amgen Inc. AMGN.MX | $5,270 312.05 USD |
-4.37
|
$2.85T 168.76B USD | $6 0.36 USD | $5,270 312.05 USD | $5,270 312.05 USD | $2.85T 168.76B USD | 26.10 | $201.84 11.95 USD | |
| Amgen Inc. AMGN34.SA | $55.12 11.17 USD |
+2.53
|
$829.88B 168.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $829.88B 168.2B USD | 24.82 | $2.22 0.45 USD | |
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1 — | $0 — | $0 — | $157.63B — | 19.38 | $14.84 — | |
| Pfizer Inc. PFE.MX | $462 27.36 USD |
+0.43
|
$2.64T 156.32B USD | $583 34.52 USD | $459.8 27.23 USD | $463.23 27.43 USD | $2.64T 156.32B USD | 17.32 | $26.66 1.58 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,100 124.35 USD |
0
|
$2.61T 154.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61T 154.68B USD | 22.93 | $91.56 5.42 USD | |
| Pfizer Inc. PFIZ34.SA | $33.42 6.77 USD |
+1.49
|
$760.02B 154.04B USD | $0 0 USD | $0 0 USD | $0 0 USD | $760.02B 154.04B USD | 17.31 | $1.93 0.39 USD | |
| Gilead Sciences, Inc. GILD34.SA | $293.72 59.53 USD |
-0.58
|
$732.99B 148.57B USD | $0 0 USD | $0 0 USD | $0 0 USD | $732.99B 148.57B USD | 22.47 | $13.07 2.65 USD | |
| Pfizer Inc. PFEB.F | $7.35 8.03 USD |
+10.53
|
$131.71B 143.98B USD | $40 43.73 USD | $6.75 7.38 USD | $7.35 8.03 USD | $131.71B 143.98B USD | 18.37 | $0.4 0.44 USD | |
| Amgen Inc. AMG.F | $240.3 262.68 USD |
+1.03
|
$129.98B 142.08B USD | $12 13.12 USD | $238.45 260.66 USD | $240.3 262.68 USD | $129.98B 142.08B USD | 26.37 | $9.11 9.96 USD | |
| Amgen Inc. AMG.DE | $240.35 262.74 USD |
+0.97
|
$129.89B 141.99B USD | $22 24.05 USD | $237.7 259.84 USD | $240.35 262.74 USD | $129.89B 141.99B USD | 26.15 | $9.19 10.05 USD | |
| Amgen Inc. AMGN.VI | $237.85 260 USD |
+0.13
|
$128.81B 140.81B USD | $1 1.09 USD | $237.85 260 USD | $239.25 261.53 USD | $128.81B 140.81B USD | 25.99 | $9.15 10 USD | |
| Gilead Sciences, Inc. GILD.SN | $110.43 — |
0
|
$137.37B — | $0 — | $0 — | $0 — | $137.37B — | 23.19 | $4.76 — | |
| Pfizer Inc. PFE.SN | $23.8 — |
-8.67
|
$135.31B — | $0 — | $0 — | $0 — | $135.31B — | 17.24 | $1.38 — | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Bristol-Myers Squibb Company BMY.BA | $18,625 22.02 USD |
-0.13
|
$112.12T 132.52B USD | $717 0.85 USD | $18,425 21.78 USD | $18,850 22.28 USD | $112.12T 132.52B USD | 5.96 | $3.12K 3.69 USD | |
| Pfizer Inc. PFE.VI | $20.98 22.93 USD |
+0.77
|
$120.09B 131.27B USD | $54 59.03 USD | $20.98 22.93 USD | $21 22.96 USD | $120.09B 131.27B USD | 17.48 | $1.2 1.31 USD | |
| Gilead Sciences, Inc. GIS.F | $92.14 100.72 USD |
+0.22
|
$115.23B 125.96B USD | $65 71.05 USD | $92.14 100.72 USD | $92.14 100.72 USD | $115.23B 125.96B USD | 22.41 | $4.11 4.49 USD | |
| Gilead Sciences, Inc. GILD.VI | $92.19 100.78 USD |
+0.13
|
$115.13B 125.85B USD | $0 0 USD | $92.19 100.78 USD | $92.41 101.02 USD | $115.13B 125.85B USD | 22.26 | $4.14 4.53 USD | |
| Gilead Sciences, Inc. GIS.DE | $92.2 100.79 USD |
0
|
$114.98B 125.69B USD | $3 3.28 USD | $92.2 100.79 USD | $92.58 101.2 USD | $114.98B 125.69B USD | 22.16 | $4.16 4.55 USD | |
| Sanofi SNW2.F | $41.8 45.69 USD |
+0.48
|
$102.35B 111.88B USD | $10 10.93 USD | $41.8 45.69 USD | $41.8 45.69 USD | $102.35B 111.88B USD | 16.58 | $2.52 2.75 USD | |
| Sanofi SNW.F | $83.6 91.39 USD |
-0.43
|
$101.79B 111.27B USD | $150 163.97 USD | $83.6 91.39 USD | $84.07 91.9 USD | $101.79B 111.27B USD | 16.71 | $5 5.47 USD | |
| Sanofi SANO.VI | $83.51 91.29 USD |
-0.3
|
$101.68B 111.15B USD | $0 0 USD | $83.51 91.29 USD | $83.56 91.34 USD | $101.68B 111.15B USD | 16.63 | $5.02 5.49 USD | |
| GSK plc GSK.BA | $11,525 13.62 USD |
+1.77
|
$93.31T 110.29B USD | $87 0.1 USD | $11,450 13.53 USD | $11,600 13.71 USD | $93.31T 110.29B USD | 18.97 | $607.37 0.72 USD | |
| Bristol-Myers Squibb Company BMY.MX | $894 52.94 USD |
-1.87
|
$1.83T 108.25B USD | $1.64K 96.81 USD | $894 52.94 USD | $911 53.94 USD | $1.83T 108.25B USD | 17.66 | $50.6 3 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $259.74 52.65 USD |
+0.4
|
$528.59B 107.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $528.59B 107.14B USD | 17.47 | $14.86 3.01 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $791 46.84 USD |
0
|
$1.6T 94.8B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.6T 94.8B USD | 20.12 | $39.31 2.33 USD | |
| Chugai Pharmaceutical CHGCF | $54.3 — |
0
|
$93.09B — | $200 — | $52 — | $52 — | $93.09B — | 31.94 | $1.7 — | |
| Bristol-Myers Squibb Company BRM.F | $40.87 44.67 USD |
+0.45
|
$83.16B 90.91B USD | $240 262.35 USD | $40.58 44.36 USD | $40.87 44.67 USD | $83.16B 90.91B USD | 17.31 | $2.36 2.58 USD | |
| Bristol-Myers Squibb Company BRM.DE | $40.58 44.36 USD |
+0.17
|
$82.67B 90.37B USD | $3.36K 3.68K USD | $40.54 44.31 USD | $41.2 45.04 USD | $82.67B 90.37B USD | 17.34 | $2.34 2.56 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $40.51 44.28 USD |
+0.05
|
$82.56B 90.25B USD | $183 200.04 USD | $40.51 44.28 USD | $40.65 44.43 USD | $82.56B 90.25B USD | 17.30 | $2.34 2.56 USD | |
| GSK plc G1SK34.SA | $41.96 8.5 USD |
0
|
$424.93B 86.13B USD | $0 0 USD | $0 0 USD | $0 0 USD | $424.93B 86.13B USD | 18.56 | $2.26 0.46 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $44.5 48.64 USD |
+0.54
|
$73.64B 80.5B USD | $67 73.24 USD | $44.44 48.58 USD | $44.5 48.64 USD | $73.64B 80.5B USD | 30.06 | $1.48 1.62 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $19.82 21.66 USD |
-1.86
|
$37.64B 41.14B USD | $50 54.66 USD | $19.81 21.66 USD | $19.82 21.66 USD | $37.64B 41.14B USD | 21.30 | $0.93 1.02 USD | |
| Bayer Aktiengesellschaft BAYZF | $31 — |
0
|
$30.74B — | $100 — | $30.35 — | $30.35 — | $30.74B — | 0 | -$3.82 — | |
| Bayer Aktiengesellschaft BAYER.BD | $10,900 30.15 USD |
0
|
$10.71T 29.62B USD | $41 0.11 USD | $10,900 30.15 USD | $10,900 30.15 USD | $10.71T 29.62B USD | 0 | -$1,336 -3.6 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $26.27 28.72 USD |
-1.07
|
$25.81B 28.21B USD | $0 0 USD | $26.27 28.72 USD | $26.47 28.93 USD | $25.81B 28.21B USD | 0 | -$3.35 -3.6 USD | |
| Bayer Aktiengesellschaft BAYA.F | $6.45 7.05 USD |
-4.44
|
$25.35B 27.71B USD | $1.11K 1.21K USD | $6.45 7.05 USD | $6.45 7.05 USD | $25.35B 27.71B USD | 0 | -$0.88 -0.9 USD | |
| Biogen Inc. BIIB.BA | $11,550 13.65 USD |
+1.76
|
$21.68T 25.63B USD | $315 0.37 USD | $11,500 13.59 USD | $11,625 13.74 USD | $21.68T 25.63B USD | 0.96 | $12.02K 14.21 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $41.8 45.69 USD |
+0.97
|
$22.29B 24.36B USD | $5 5.47 USD | $41.8 45.69 USD | $41.8 45.69 USD | $22.29B 24.36B USD | 10.71 | $3.9 4.26 USD | |
| Biogen Inc. BIIB34.SA | $124.32 25.2 USD |
0
|
$109.74B 22.24B USD | $0 0 USD | $0 0 USD | $0 0 USD | $109.74B 22.24B USD | 13.41 | $9.27 1.88 USD | |
| Biogen Inc. BIIB.MX | $2,550 150.99 USD |
0
|
$373.65B 22.12B USD | $0 0 USD | $0 0 USD | $0 0 USD | $373.65B 22.12B USD | 13.08 | $194.82 11.54 USD | |
| Astellas Pharma ALPMF | $10.1 — |
0
|
$18.08B — | $100 — | $10.1 — | $10.1 — | $18.08B — | 53.15 | $0.19 — | |
| Biogen Inc. IDP.DE | $109.8 120.03 USD |
+0.97
|
$16.11B 17.61B USD | $61 66.68 USD | $108 118.06 USD | $110.1 120.35 USD | $16.11B 17.61B USD | 12.43 | $8.83 9.65 USD | |
| Biogen Inc. BIIB.VI | $108.9 119.04 USD |
+0.18
|
$15.99B 17.48B USD | $0 0 USD | $108.9 119.04 USD | $108.95 119.1 USD | $15.99B 17.48B USD | 12.37 | $8.8 9.62 USD | |
| Biogen Inc. IDP.F | $108.3 118.39 USD |
-1.05
|
$15.87B 17.35B USD | $50 54.66 USD | $108.3 118.39 USD | $108.3 118.39 USD | $15.87B 17.35B USD | 12.26 | $8.83 9.65 USD | |
| Astellas Pharma Inc. YPH.F | $8.1 8.86 USD |
+1.35
|
$14.9B 16.29B USD | $100 109.31 USD | $8.1 8.86 USD | $8.1 8.86 USD | $14.9B 16.29B USD | 50.63 | $0.16 0.17 USD | |
| Astellas Pharma Inc. YPHA.F | $7.9 8.64 USD |
0
|
$14.7B 16.07B USD | $680 743.33 USD | $7.9 8.64 USD | $7.9 8.64 USD | $14.7B 16.07B USD | 46.47 | $0.17 0.19 USD | |
| Cipla Limited CIPLA.BO | $1,510 18.27 USD |
+0.48
|
$1.22T 14.76B USD | $15.7K 189.96 USD | $1,500 18.15 USD | $1,519.1 18.38 USD | $1.22T 14.76B USD | 23.15 | $65.22 0.79 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $54.1 59.14 USD |
+0.37
|
$11.13B 12.17B USD | $40 43.73 USD | $54.1 59.14 USD | $54.1 59.14 USD | $11.13B 12.17B USD | 27.05 | $2 2.19 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $54.1 59.14 USD |
0
|
$11.13B 12.17B USD | $0 0 USD | $54.1 59.14 USD | $54.3 59.36 USD | $11.13B 12.17B USD | 27.05 | $2 2.19 USD | |
| CSPC Pharmaceutical CHJTF | $1.05 — |
0
|
$11.99B — | $19.71K — | $1.05 — | $1.05 — | $11.99B — | 20.99 | $0.05 — | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.89 0.97 USD |
+4.43
|
$10.45B 11.43B USD | $824 900.74 USD | $0.89 0.97 USD | $0.89 0.97 USD | $10.45B 11.43B USD | 17.81 | $0.05 0.05 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $3.26 3.56 USD |
+0.62
|
$10.07B 11.01B USD | $4.35K 4.75K USD | $3.26 3.56 USD | $3.26 3.56 USD | $10.07B 11.01B USD | 18.11 | $0.18 0.2 USD | |
| CSPC Pharmaceutical CSPCY | $3.84 — |
0
|
$10.95B — | $2.65K — | $3.85 — | $3.85 — | $10.95B — | 18.26 | $0.21 — | |
| Orion Oyj ORINY | $37.53 — |
0
|
$10.4B — | $8 — | $37.99 — | $37.99 — | $10.4B — | 26.42 | $1.42 — | |
| Orion Oyj OFK.F | $63.05 68.92 USD |
0
|
$8.86B 9.68B USD | $352 384.78 USD | $63.05 68.92 USD | $63.05 68.92 USD | $8.86B 9.68B USD | 25.73 | $2.45 2.68 USD | |
| Orion Oyj OFK0.F | $31.4 34.32 USD |
-3.09
|
$8.59B 9.39B USD | $0 0 USD | $31.4 34.32 USD | $31.4 34.32 USD | $8.59B 9.39B USD | 24.92 | $1.26 1.38 USD | |
| Kyowa Kirin KYKOF | $17.14 — |
0
|
$8.97B — | $100 — | $15.8 — | $15.8 — | $8.97B — | 25.58 | $0.67 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $14.5 15.85 USD |
-0.68
|
$7.63B 8.34B USD | $30 32.79 USD | $14.5 15.85 USD | $14.5 15.85 USD | $7.63B 8.34B USD | 25.00 | $0.58 0.63 USD | |
| Abbott India Limited ABBOTINDIA.BO | $31,692.35 383.42 USD |
+0.58
|
$673.44B 8.15B USD | $121 1.46 USD | $31,460 380.61 USD | $31,750 384.12 USD | $673.44B 8.15B USD | 47.66 | $664.87 8.04 USD | |
| Abbott India Limited ABBOTINDIA.NS | $31,680 383.28 USD |
+0.46
|
$673.18B 8.14B USD | $5.19K 62.8 USD | $31,365 379.46 USD | $31,795 384.67 USD | $673.18B 8.14B USD | 47.61 | $665.39 8.05 USD | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Grifols, S.A. GIKLY | $6.14 — |
0
|
$7.09B — | $1K — | $5.33 — | $5.33 — | $7.09B — | 47.23 | $0.13 — | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||
- {{ link.label }} {{link}}